Ibex Medical Analytics Establishes Biopharma Advisory Board to Advance AI-Powered Precision Diagnostics
Ibex Medical Analytics established a Biopharma Advisory Board announced on May 5, 2026
The advisory board is designed to advance AI-powered precision diagnostics
The company expanded its biopharma business extending AI pathology platform into early biomarker development
Ibex is a global leader in clinical-grade AI-powered pathology
The expansion extends the AI-powered product offering into biomarker development for biopharma applications